These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2433726)

  • 21. New class I in man: serological and molecular characterization.
    Fauchet R; Boscher M; Bouhallier O; Merdrignac G; Genetet B; Turmel P; Charron DJ
    Hum Immunol; 1986 Sep; 17(1):3-20. PubMed ID: 3488984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological identification of five HLA-D associated (Ia-like) determinants.
    Albrechtsen D; Solheim BG; Thorsby E
    Tissue Antigens; 1977 Mar; 9(3):153-62. PubMed ID: 67654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
    Yannelli JR; Moore LC; Engelhard VH
    J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alloantigens expressed on a subset of unstimulated human T lymphocytes that generate suppressor function.
    Okada J; Stastny P
    Immunogenetics; 1982; 16(1):59-70. PubMed ID: 6180983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simplification of B-cell antisera of the Merrit system with platelets and lymphoblastoid cell lines.
    Naeim F; Gregg B; Gatti RA; Leibold W; Walford RL
    Transplant Proc; 1977 Mar; 9(1):439-44. PubMed ID: 68582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitation of beta2-microglobulin and HLA on the surface of human cells. I. T and B lymphocytes and lymphoblasts.
    Dorval G; Welsh KI; Nilsson K; Wigzell H
    Scand J Immunol; 1977; 6(4):255-63. PubMed ID: 67632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of T and B lymphocytes in vitro. III. Presence of Ia determinants on allogeneic effect factor.
    Armerding D; Sachs DH; Katz DH
    J Exp Med; 1974 Dec; 140(6):1717-22. PubMed ID: 4139236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of a human major histocompatibility complex class I gene encoding a nonubiquitous molecule expressed on activated lymphocytes.
    Paul P; Fauchet R; Boscher MY; Sayagh B; Masset M; Medrignac G; Dausset J; Cohen D
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2872-6. PubMed ID: 3033667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of reactivity of HLA-Cw antisera by extending the incubation time.
    Wong DM; Kumar R; Mittal KK
    Acta Anthropogenet; 1983; 7(3):197-203. PubMed ID: 6335043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IEF analysis of HLA molecules immunoprecipitated by putative anti-class I-like alloantisera.
    Crepaldi T; D'Alfonso S; Richiardi P
    J Immunogenet; 1990 Dec; 17(6):409-13. PubMed ID: 1710635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-D restriction of the macrophage-dependent response of immune human T lymphocytes to PPD in vitro: inhibition by anti-HLA-DR antisera.
    Bergholtz BO; Thorsby E
    Scand J Immunol; 1978; 8(1):63-73. PubMed ID: 81515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B lymphocyte alloantigen specificities present on cultured lymphoblastoid cell lines.
    Honig R; Billing R; Matsuyama M; Terasaki PJ
    J Immunol; 1976 Oct; 117(4):1300-2. PubMed ID: 61996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of human class I antigens by two-dimensional gel electrophoresis. I. Polymorphism, evidence for additional (non-HLA-A, B, C) gene products, and identification of variant HLA-A, B antigens.
    Vasilov RG; Hahn A; Mölders H; van Rood JJ; Breuning M; Ploegh HL
    Immunogenetics; 1983; 17(4):333-56. PubMed ID: 6187677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-2 activated lymphocytes show improved sensitivity for class 1 HLA typing.
    Hirose M; Shinohara K; Watanabe H; Lee E; Kuroda Y
    Tokushima J Exp Med; 1996 Dec; 43(3-4):87-91. PubMed ID: 9100455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A "private" DR antigen associated with HLA-B37.
    Jakobsen BK; Svejgaard A
    Tissue Antigens; 1979 Oct; 14(4):361-4. PubMed ID: 94709
    [No Abstract]   [Full Text] [Related]  

  • 36. Monoclonal mouse anti-I-Ak and anti-I-Ek antibodies cross-reacting with HLA-DR supertypic and subtypic determinants rather than classical DR allelic specificities.
    Pierres M; Mercier P; Madsen M; Mawas C; Kristensen T
    Tissue Antigens; 1982 Apr; 19(4):289-300. PubMed ID: 6179258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated human T cells express beta 2-microglobulin-associated HLA-A,B,C molecules not recognized by W6/32 mAb.
    Crepaldi T; D'Alfonso S; Richiardi P
    Tissue Antigens; 1991 Mar; 37(3):138-40. PubMed ID: 1871766
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study of the HLA-DQ system by the complement fixation test on lymphocytes stimulated by phytohemagglutinin. Existence of HLA-DQX allele(s)].
    Chidiac A; Colombani M; Lepage V; Raffoux C; Sansonetti N; Colombani J
    Rev Fr Transfus Immunohematol; 1986 Apr; 29(2):65-79. PubMed ID: 3092321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA segregation of human T-cell subpopulation markers.
    Ferrara GB; Longo A; Tosi R; Biagini A; Mennucci M; Carminati G
    Hum Immunol; 1981 May; 2(3):213-23. PubMed ID: 7021492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in the detectability of HLA antigens on lymphocyte subpopulations induced by mitogens and corticosteroids].
    Volgin AIu; Pevnitskiĭ LA
    Biull Eksp Biol Med; 1982 Jan; 93(1):45-7. PubMed ID: 6978158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.